Biowaiver monographs for immediate release solid oral dosage forms: furosemide.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Pharmacy and Science

• Publication date

  2010-06-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1002/jps.22030PMID 19960529
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Rediguieri CF, Porta V, Nunes DSG, Nunes TM, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Dressman JB, Barends DM. 2011. Biowaiver monographs for immediate‐release solid oral dosage forms: Metronidazole. J Pharm Sci 100:1618–1627.

  2011cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: Doxycycline hyclate.

  2010cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: rifampicin.

  2009cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: quinidine sulfate.

  2009cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: diclofenac sodium and diclofenac potassium.

  2009cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: ethambutol dihydrochloride.

  2008cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: aciclovir.

  2008cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: metoclopramide hydrochloride.

  2008cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: acetazolamide.

  2008cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: pyrazinamide.

  2008cited by this paper
• Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes.

  2007cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: isoniazid.

  2007cited by this paper
• Combined assessment of dissolution and epithelial permeability of solid oral dosage forms

  2007cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: prednisolone.

  2007cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: prednisone.

  2007cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: acetaminophen (paracetamol).

  2006cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: cimetidine.

  2006cited by this paper
• A new drug nanocarrier consisting of chitosan and hydoxypropylcyclodextrin.

  2006cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: amitriptyline hydrochloride.

  2006cited by this paper
• Molecular dynamics of solid furosemide (4-chloro-2-furfurylamino-5-sulfamoyl-benzoic acid) studied by NMR and DFT methods

  2006cited by this paper
• Multisource (generic) pharmaceutical products: guidelines on registration requirements to establish interchangeability

  2006cited by this paper
• Development and evaluation of an in vitro method for prediction of human drug absorption II. Demonstration of the method suitability.

  2006cited by this paper
• Prediction of the permeability of drugs through study on quantitative structure-permeability relationship.

  2006cited by this paper
• Influence of vitamin E TPGS poly(ethylene glycol) chain length on apical efflux transporters in Caco-2 cell monolayers.

  2006cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: chloroquine phosphate, chloroquine sulfate, and chloroquine hydrochloride.

  2005cited by this paper
• PROPOSAL TO WAIVE IN VIVO BIOEQUIVALENCE REQUIREMENTS FOR THE WHO MODEL LIST OF ESSENTIAL MEDICINES IMMEDIATE RELEASE, SOLID ORAL DOSAGE FORMS

  2005cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: ranitidine hydrochloride.

  2005cited by this paper
• Trends in solubility of polymorphs.

  2005cited by this paper
• Biowaiver monographs for immediate release solid oral dosage forms: ibuprofen.

  2005cited by this paper
• Classification of orally administered drugs on the World Health Organization Model list of Essential Medicines according to the biopharmaceutics classification system.

  2004cited by this paper
• Implications of intraindividual variability in bioavailability studies of furosemide

  2004influential reference
• Predicting Drug Disposition via Application of BCS: Transport/Absorption/ Elimination Interplay and Development of a Biopharmaceutics Drug Disposition Classification System

  2004cited by this paper
• Pharmacokinetics of furosemide in man after intravenous and oral administration. Application of moment analysis

  2004influential reference
• Reduced bioavailability and effect of furosemide given with food

  2004cited by this paper
• Molecular properties of WHO essential drugs and provisional biopharmaceutical classification.

  2004influential reference
• Biowaiver monographs for immediate release solid oral dosage forms based on biopharmaceutics classification system (BCS) literature data: verapamil hydrochloride, propranolol hydrochloride, and atenolol.

  2004cited by this paper
• Micellar versus hydro-organic mobile phases for retention-hydrophobicity relationship studies with ionizable diuretics and an anionic surfactant.

  2004cited by this paper
• Bioequivalence evaluation of two brands of furosemide 40mg tablets (Salurin and Lasix) in healthy human volunteers

  2003influential reference
• Therapeutic and toxic blood concentrations of more than 800 drugs and other xenobiotics.

  2003cited by this paper
• Physicochemical characterization of solid dispersion of furosemide with TPGS.

  2003cited by this paper
• In vivo Pharmacokinetic Pharmacodynamic Relationship and in vitro Equivalence of Two Oral Furosemide Tablet Formulations

  2003influential reference
• Quantitative Biopharmaceutics Classification System: The Central Role of Dose/Solubility Ratio

  2003influential reference
• Supac-Mr: Modified Release Solid Oral Dosage Forms‚ÄîScale-Up and Postapproval Changes: Chemistry, Manufacturing, and Controls; In Vitro Dissolution Testing and In Vivo Bioequivalence Documentation

  2001cited by this paper
• Caco-2 monolayers in experimental and theoretical predictions of drug transport1PII of original article: S0169-409X(96)00415-2. The article was originally published in Advanced Drug Delivery Reviews 22 (1996) 67–84.1

  2001cited by this paper
• Effect of common excipients on Caco-2 transport of low-permeability drugs.

  2001influential reference
• Waiver of In Vivo Bioavailability and Bioequivalence Studies for Immediate-Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System

  2001cited by this paper
• Caco-2 monolayers in experimental and theoretical predictions of drug transport.

  2001cited by this paper
• Evaluation of the Intelisite capsule to deliver theophylline and frusemide tablets to the small intestine and colon.

  2001cited by this paper
• Structure-Solubility Relationship and Thermal Decomposition of Furosemide

  2000cited by this paper
• Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.

  2000cited by this paper
• Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells.

  2000cited by this paper
• Net Secretion of Furosemide Is Subject to Indomethacin Inhibition, as Observed in Caco-2 Monolayers and Excised Rat Jejunum

  1999cited by this paper
• Hydrophobicity of Ionizable Compounds. A Theoretical Study and Measurements of Diuretic Octanol−Water Partition Coefficients by Countercurrent Chromatography

  1999cited by this paper
• Martindale: The Complete Drug Reference

  1999cited by this paper
• Correlation of human jejunal permeability (in vivo) of drugs with experimentally and theoretically derived parameters. A multivariate data analysis approach.

  1998cited by this paper
• Correlation Between Oral Drug Absorption in Humans, and Apparent Drug Permeability in TC-7 Cells, A Human Epithelial Intestinal Cell Line: Comparison with the Parental Caco-2 Cell Line

  1998cited by this paper
• Assessment of pharmaceutical quality of furosemide tablets from multinational markets.

  1998cited by this paper
• Estimation of the Relative Contribution of the Transcellular and Paracellular Pathway to the Transport of Passively Absorbed Drugs in the Caco-2 Cell Culture Model

  1997cited by this paper
• Determination of bioequivalence of two furosemide preparations; the effect of high doses of furosemide on some pharmacokinetic parameters.

  1996cited by this paper
• A bioequivalence study of two products of furosemide tablets.

  1992cited by this paper
• Furosemide (Frusemide) A Pharmacokinetic/Pharmacodynamic Review (Part I)

  1990cited by this paper
• Furosemide (frusemide). A pharmacokinetic/pharmacodynamic review (Part II).

  1990influential reference
• Bioavailability and pharmacokinetics of furosemide marketed in Thailand.

  1990cited by this paper
• Physicochemical characterization of furosemide modifications

  1990cited by this paper
• Furosemide pharmacokinetics and pharmacodynamics in health and disease—An update

  1989cited by this paper
• Comparative bioavailability of furosemide from solution and 40 mg tablets with different dissolution characteristics following oral administration in normal men

  1988influential reference
• Influence of Tablet Dissolution on Furosemide Bioavailability: A Bioequivalence Study

  1987influential reference
• Bioavailability of seven furosemide tablets in man.

  1986cited by this paper
• Pharmacokinetics of furosemide after three different single oral doses.

  1985cited by this paper
• An in‐vivo ‐ in‐vitro correlation for the bioavailability of frusemide tablets

  1984influential reference
• Comparative bioavailability of two furosemide formulations in humans.

  1984cited by this paper
• Disposition and absolute bioavailability of furosemide in healthy males.

  1982cited by this paper
• Dissolution medium—a critical parameter to identify bioavailability problems of furosemide tablets

  1982influential reference
• The pharmaceutical and biological availability of commercial preparations of furosemide.

  1982cited by this paper
• Absorption and disposition of furosemide in healthy volunteers, measured with a metabolite-specific assay.

  1980cited by this paper
• Bioavailability of frusemide.

  1980cited by this paper
• Gastrointestinal sites of furosemide absorption in rats

  1979cited by this paper
• Clinical Pharmacokinetics of Frusemide

  1979cited by this paper
• Bioavailability of two frusemide preparations.

  1978cited by this paper
• The Effect of Four Tablet Binders on the Bioavailability of Frusemide from 40MG Tablets

  1978cited by this paper
• The United States Pharmacopeial Convention, Inc

  1977cited by this paper
• Some aspects of the photochemical degradation of frusemide.

  1977cited by this paper
• Some aspects of the photochemical degradation of frusemide.

  1976cited by this paper
• Pharmacokinetics of orally administered furosemide

  1974cited by this paper

• By Chance, Not Design: A New Furosemide Derivative From Zinc(II) Complex Studies.

  2026cites this paper
• New coordination modes of furosemide anion in copper(II) complexes: synthesis and structural insights

  2025cites this paper
• Maintaining the stability of furosemide tablets during enteral feeding tube delivery using PVC and non-PVC tubes, in accordance with hospital protocols

  2025cites this paper
• On zinc(ii) coordination chemistry with furosemide: a journey from a mononuclear complex to a coordination polymer

  2025cites this paper
• Furosemide nanosuspensions: Preparation, characterization and evaluation of the interplay between solubility and permeability

  2025cites this paper
• Comparative evaluation of amiodarone and furosemide compatibility under different mixing conditions

  2025influential citation
• Bifunctional competitive antigen enhanced DLS Immunosensor for the ultrasensitive detection of furosemide in slimming products.

  2025cites this paper
• Automated 3D Printing of Pediatric Furosemide Tablets: A Personalized Medicine Approach Using Semi-Solid Extrusion and NIR Monitoring.

  2025cites this paper
• Quantitative analysis of excipients to the permeability of BCS class III drugs.

  2024cites this paper
• Coupling Drug Dissolution with BCS

  2024cites this paper
• Solid-Liquid Equilibrium Behavior and Data Correlation of Furosemide in 12 Pure Solvents from 283.15 to 323.15 K

  2024cites this paper
• Intravenous delivery of furosemide using lipid-based versus polymer-based nanocapsules: in vitro and in vivo studies

  2024cites this paper
• A Perspective on the Permeability of Cocrystals/Organic Salts of Oral Drugs.

  2024cites this paper
• Development of a quaternary ammonium poly (amidoamine) dendrimer-based drug carrier for the solubility enhancement and sustained release of furosemide

  2023cites this paper
• Formulation and In Vitro Evaluation of Furosemide Floating Matrix Tablets Using Boswellia papyrifera Resin as Matrix Forming Polymer

  2023cites this paper
• Properties of Pluronic F68 and F127 micelles interacting furosemide from coarse-grained molecular simulations as validated by experiments

  2023cites this paper
• Ultrabright red-emitted aggregation-induced luminescence microspheres-based lateral flow immunoassay for furosemide detection in slimming products

  2023cites this paper
• Formulation and Evaluation of Self-Nanoemulsifying Drug Delivery System Derived Tablet Containing Sertraline

  2022cites this paper
• Preparation and Characterization of Furosemide Solid Dispersion with Enhanced Solubility and Bioavailability

  2022cites this paper
• Solubility enhancement of caffeine and furosemide using deep eutectic solvents formed by choline chloride and xylitol, citric acid, sorbitol or glucose

  2022cites this paper
• Functional block copolymer micelles based on poly (jasmine lactone) for improving the loading efficiency of weakly basic drugs

  2022cites this paper
• Self-propelled Janus micromotors for pH-responsive release of small molecule drug

  2022cites this paper
• Formulation and Evaluation of a Furosemide Nanosuspension Using High-Pressure Homogenization for Enhanced Dissolution Rate

  2022cites this paper
• Investigating Halloysite Nanotubes as a Potential Platform for Oral Modified Delivery of Different BCS Class Drugs: Characterization, Optimization, and Evaluation of Drug Release Kinetics

  2021cites this paper
• Formulation and Comparative in-vitro Evaluation of Mucoadhesive Buccal Tablets of Furosemide

  2021influential citation
• Visible Quantitative Methods for the Estimation of Furosemide in Pure form and Pharmaceutical Formulations

  2021cites this paper
• Lateral Flow Immunochromatography Assay for Detection of Furosemide in Slimming Health Foods

  2021cites this paper
• A toolbox for mimicking gastrointestinal conditions in children: Simulated Paediatric Breakfast Media (SPBM) for addressing the variability of gastric contents after typical paediatric breakfasts.

  2021cites this paper
• 3D printed furosemide and sildenafil tablets: innovative production and quality control.

  2021cites this paper
• Effect of precipitation inhibitors on supersaturation and solubility of furosemide

  2021influential citation
• Comparison of Generic Furosemide Products by In Vitro Release Studies using USP Apparatus 2 and 4

  2021cites this paper
• Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs

  2021cites this paper
• In vitro release studies of furosemide reference tablets: influence of agitation rate, USP apparatus, and dissolution media

  2020cites this paper
• Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties. Case Study: Superdisintegrants

  2020cites this paper
• ESTUDO DE EQUIVALÊNCIA FARMACÊUTICA ENTRE COMPRIMIDOS DE FUROSEMIDA SIMILARES E GENÉRICOS

  2020cites this paper
• Papain-cyclodextrin complexes as an intestinal permeation enhancer: Permeability and in vitro safety evaluation

  2020cites this paper
• Comparison between Branded and Generic Furosemide 40 mg Tablets Using Thermal Gravimetric Analysis and Fourier Transform Infrared Spectroscopy

  2020cites this paper
• Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study—Hypromellose (HPMC)

  2020cites this paper
• Synthesis and characterization of furosemide‐loaded sericin/alginate beads subjected to thermal or chemical cross‐linking for delayed and sustained release

  2020cites this paper
• Development of a modified drug delivery system through the incorporation of furosemide into sericin and alginate matrix using the experimental design approach

  2020cites this paper
• Contribution of Uptake and Efflux Transporters to Oral Pharmacokinetics of Furosemide

  2020cites this paper
• Investigation of hydroxypropyl-β-cyclodextrin inclusion complexation of two poorly soluble model drugs and their taste-sensation - Effect of electrolytes, freeze-drying and incorporation into oral film formulations

  2020cites this paper
• Controlled Drug Release from Biodegradable Polymer Matrix Loaded in MicrocontainersUsing Hot Punching

  2020cites this paper
• EQUIVALENCE STUDY OF IMMEDIATE RELEASE TABLETS OF BETA BLOCKER DRUG

  2020cites this paper
• Impact of Magnesium Stearate Presence and Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties

  2020cites this paper
• Furosemide Adducts with Hexamethylenetetramine, Amantadine, and Isoniazid: A Structural Case That Demonstrates the Effect of Carboxylic Acid Dimer and Sulfonic Acid Dimer on the Solubility

  2020cites this paper
• Enhancing the solubility and permeability of the diuretic drug furosemide via multicomponent crystal forms.

  2020cites this paper
• An improved drop casting electrochemical strategy for furosemide quantification in natural waters exploiting chemically reduced graphene oxide on glassy carbon electrodes

  2020cites this paper
• Enhancing the Furosemide Permeability by Papain Minitablets Through a Triple Co-culture In Vitro Intestinal Cell Model

  2020cites this paper
• BCS Class IV Oral Drugs and Absorption Windows: Regional-Dependent Intestinal Permeability of Furosemide

  2020cites this paper
• Physiologically Based Pharmacokinetic Models of Probenecid and Furosemide to Predict Transporter Mediated Drug-Drug Interactions

  2020cites this paper
• Controlled Drug Release from Biodegradable Polymer Matrix Loaded in Microcontainers Using Hot Punching

  2020cites this paper
• Investigation of drug partition kinetics to fat in simulated fed state gastric conditions based on drug properties.

  2020cites this paper
• Modified release of furosemide from Eudragits® and poly(ethylene oxide)-based matrices and dry-coated tablets

  2019cites this paper
• Mucoadhesive buccal films based on a graft co-polymer - A mucin-retentive hydrogel scaffold.

  2019cites this paper
• Pharmaceutical Equivalence and Stability of Furosemide Tablets in Argentina

  2019cites this paper
• The comparative study of cocrystal/salt in simultaneously improving solubility and permeability of acetazolamide

  2019cites this paper
• Nephrotic Syndrome: Oedema Formation and Its Treatment With Diuretics

  2019cites this paper
• Application of data mining approach to identify drug subclasses based on solubility and permeability

  2019cites this paper
• Micellisation Mechanism and Behaviour of Soluplus®–Furosemide Micelles: Preformulation Studies of an Oral Nanocarrier-Based System

  2019cites this paper
• Modifying release of poorly soluble active pharmaceutical ingredients with the amine functionalized SBA-16 type mesoporous materials

  2019cites this paper
• A High-Demanding Strategy to Ensure the Highest Quality Standards of Oral Liquid Individualized Medicines for Pediatric Use

  2019cites this paper
• Development of daidzein nanosuspensions: Preparation, characterization, in vitro evaluation, and pharmacokinetic analysis.

  2019cites this paper
• Eficiência de incorporação de furosemida em partículas desenvolvidas a partir de blenda de sericina e alginato

  2019cites this paper
• TASTE MASKING BY HOT MELT EXTRUSION WITHOUT LOSS OF BIOAVAILABILITY FOR PEDIATRICS

  2019cites this paper
• Synthesis, Structures and Various Biological Applications of New Zn(II) Complexes Having Different Coordination Modes Controlled by the Drug Furosemide in Presence of Bioactive Nitrogen Based Ligands

  2018cites this paper
• Integrating theoretical and experimental permeability estimations for provisional biopharmaceutical classification: Application to the WHO essential medicines

  2018cites this paper
• Preparation and characterization of furosemide nanosuspensions

  2018cites this paper
• Toward Improved Understanding of the Interactions between Poorly Soluble Drugs and Cellulose Nanofibers.

  2018cites this paper
• Artificial Lipid Membrane Permeability Method for Predicting Intestinal Drug Transport: Probing the Determining Step in the Oral Absorption of Sulfadiazine; Influence of the Formation of Binary and Ternary Complexes with Cyclodextrins

  2018cites this paper
• Synthesis, characterization and drug release activity of poly(epichlorohydrin-g-furosemide) system

  2018cites this paper
• Preparation and characterization of solid lipid nanoparticles of furosemide using quality by design

  2018influential citation
• Novel Strategy for the Systemic Delivery of Furosemide Based on a New Drug Transport Mechanism.

  2018cites this paper
• Non randomized study on the potential of nitisinone to inhibit cytochrome P450 2C9, 2D6, 2E1 and the organic anion transporters OAT1 and OAT3 in healthy volunteers

  2018cites this paper
• Experimental and Modeling Study of Drug Release from HPMC-Based Erodible Oral Thin Films

  2018cites this paper
• An NMR crystallography investigation of furosemide

  2018cites this paper
• Comparative evaluation of coprecipitation, solvent evaporation, and kneading as techniques to improve solubility and dissolution profiles of a BCS class IV drug

  2017cites this paper
• Mucopenetrating nanoparticles for enhancement of oral bioavailability of furosemide: In vitro and in vivo evaluation/sub-acute toxicity study.

  2017cites this paper
• Development and Characterization of an Amorphous Solid Dispersion of Furosemide in the Form of a Sublingual Bioadhesive Film to Enhance Bioavailability

  2017cites this paper
• Studying furosemide solubilization using an in vitro model simulating gastrointestinal digestion and drug solubilization in neonates and young infants

  2017cites this paper
• Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.

  2017cites this paper
• Self-Emulsifying Granules and Pellets: Composition and Formation Mechanisms for Instant or Controlled Release

  2017cites this paper
• In vitro–in vivo and pharmacokinetic evaluation of solid lipid nanoparticles of furosemide using Gastroplus™

  2017cites this paper
• EFFECT OF 70% ETHANOL EXTRACT OF ORTHOSIPHONIS STAMINEUS BENTH LEAVES ON THE PHARMACOKINETIC PARAMETERS OF FUROSEMIDE IN MALE WHITE RATS

  2017cites this paper
• The SeDeM Expert Diagram System: Its performance and predictability in direct compressible formulations containing novel excipients and different types of active ingredients

  2017cites this paper
• Spectrofluorometric determination of furosemide in some pharmaceutical product using acriflavine as a reagent

  2017cites this paper
• Efecto de la fuerza de compresión sobre los atributos críticos de calidad en tabletas de liberación inmediata de furosemida

  2017cites this paper
• Sex-related in vitro/in vivo and PK/PD correlations after oral single dose furosemide administration

  2016influential citation
• Physical–chemical properties of furosemide nanocrystals developed using rotation revolution mixer

  2016cites this paper
• Polymeric microcontainers improve oral bioavailability of furosemide.

  2016cites this paper
• Imaging of in vitro parenteral drug precipitation.

  2016cites this paper
• STUDI PENGGUNAAN FUROSEMIDE PADA PASIEN GAGAL JANTUNG DI RUMAH SAKIT MUHAMMADIYAH LAMONGAN

  2016cites this paper
• Forecasting oral absorption across biopharmaceutics classification system classes with physiologically based pharmacokinetic models

  2016cites this paper
• Biowaiver monograph for ascorbic acid immediate release solid oral dosage forms

  2016influential citation
• Synthesis and characterization of SBA-16 type mesoporous materials containing amine groups

  2016cites this paper
• OPTIMIZATION OF FUROSEMIDE LIQUISOLID TABLETS PREPARATION PROCESS LEADING TO THEIR MASS AND SIZE REDUCTION.

  2016cites this paper
• Prediction of oral drug bioavailability : from animal-based extrapolation towards the application of physiologically-based pharmacokinetic modelling and simulation

  2016cites this paper
• Cocrystal and Salt Forms of Furosemide: Solubility and Diffusion Variations

  2016cites this paper
• Fabrication and loading of microcontainers for oral drug delivery

  2015cites this paper
• Formulation of Furosemide Dispersible Tablets for Use in Paediatrics

  2015cites this paper